Provide the exact API or formulation type, required concentration, packaging size (e.g., bulk drums or bottles), order volume, target destination, and required quality standards like USP, EP, or GMP.
Category market report
Antiparasitic Drugs
Total suppliers
6,872+
Total Chinese suppliers export
$9.6B+
Recommended
High-quality suppliers related to Antiparasitic Drugs.
Suppliers
Find more suppliers who may be worth contacting.
Top suppliers
Suppliers in this category.
- Transactions
1,897
2018-012022-032026-08Transaction trend for Astrazeneca Pharmaceutical Co., Ltd.
- 2018-01: 4
- 2018-02: 2
- 2018-03: 3
- 2018-04: 4
- 2018-05: 3
- 2018-06: 10
- 2018-07: 5
- 2018-09: 10
- 2018-10: 2
- 2018-11: 1
- 2018-12: 1
- 2019-01: 32
- 2019-02: 19
- 2019-03: 17
- 2019-04: 13
- 2019-05: 19
- 2019-06: 16
- 2019-07: 9
- 2019-08: 5
- 2019-09: 4
- 2019-10: 7
- 2019-11: 13
- 2019-12: 15
- 2020-01: 24
- 2020-02: 1
- 2020-03: 18
- 2020-04: 30
- 2020-05: 27
- 2020-06: 14
- 2020-07: 13
- 2020-08: 38
- 2020-09: 4
- 2020-10: 21
- 2020-11: 28
- 2020-12: 16
- 2021-01: 9
- 2021-02: 42
- 2021-03: 23
- 2021-04: 20
- 2021-05: 44
- 2021-06: 23
- 2021-07: 19
- 2021-08: 33
- 2021-09: 15
- 2021-10: 46
- 2021-11: 27
- 2021-12: 22
- 2022-01: 43
- 2022-02: 9
- 2022-03: 22
- 2022-04: 30
- 2022-05: 24
- 2022-06: 26
- 2022-07: 19
- 2022-08: 18
- 2022-09: 19
- 2022-10: 34
- 2022-11: 12
- 2022-12: 37
- 2023-01: 13
- 2023-02: 19
- 2023-03: 51
- 2023-04: 22
- 2023-05: 12
- 2023-06: 26
- 2023-07: 23
- 2023-08: 17
- 2023-09: 45
- 2023-10: 10
- 2023-11: 32
- 2023-12: 15
- 2024-02: 28
- 2024-03: 12
- 2024-05: 31
- 2024-06: 18
- 2024-07: 16
- 2024-08: 6
- 2024-09: 15
- 2024-10: 16
- 2024-11: 11
- 2024-12: 14
- 2025-01: 21
- 2025-02: 14
- 2025-03: 19
- 2025-04: 13
- 2025-05: 9
- 2025-06: 11
- 2025-07: 20
- 2025-08: 17
- 2025-09: 13
- 2025-10: 7
- 2025-11: 13
- 2025-12: 16
- 2026-01: 21
- 2026-03: 13
- 2026-04: 49
- 2026-05: 33
- 2026-06: 25
- 2026-07: 28
- 2026-08: 14
- Amount
4,100,621.13
2018-012022-032026-08Amount trend for Astrazeneca Pharmaceutical Co., Ltd.
- 2018-01: 19.5M
- 2018-02: 23.3K
- 2018-03: 613.5K
- 2018-04: 401K
- 2018-05: 53.6K
- 2018-06: 195.8K
- 2018-07: 174.2K
- 2018-09: 1.4M
- 2018-10: 143.4K
- 2018-11: 27.6K
- 2018-12: 23K
- 2019-01: 40.7B
- 2019-02: 2.8M
- 2019-03: 2.4M
- 2019-04: 1.7M
- 2019-05: 2.6M
- 2019-06: 3.1M
- 2019-07: 1.8M
- 2019-08: 840.4K
- 2019-09: 772.1K
- 2019-10: 2.5M
- 2019-11: 2M
- 2019-12: 1.8M
- 2020-01: 7M
- 2020-02: 9,942.19
- 2020-03: 3.1M
- 2020-04: 4.1M
- 2020-05: 4.5M
- 2020-06: 5.9M
- 2020-07: 2.1M
- 2020-08: 7.6M
- 2020-09: 281.4K
- 2020-10: 1.8M
- 2020-11: 2.3M
- 2020-12: 2.1M
- 2021-01: 927.7K
- 2021-02: 5.9M
- 2021-03: 3M
- 2021-04: 2.8M
- 2021-05: 6.3M
- 2021-06: 4.1M
- 2021-07: 2.5M
- 2021-08: 4M
- 2021-09: 3.4M
- 2021-10: 7M
- 2021-11: 3.9M
- 2021-12: 4M
- 2022-01: 8.5M
- 2022-02: 2.3M
- 2022-03: 2.2M
- 2022-04: 5.2M
- 2022-05: 2.8M
- 2022-06: 4.1M
- 2022-07: 3.3M
- 2022-08: 2.1M
- 2022-09: 2.8M
- 2022-10: 5.3M
- 2022-11: 2M
- 2022-12: 5.9M
- 2023-01: 1.2M
- 2023-02: 3.3M
- 2023-03: 6.5M
- 2023-04: 3.4M
- 2023-05: 3.1M
- 2023-06: 3.4M
- 2023-07: 2.5M
- 2023-08: 2.8M
- 2023-09: 6.7M
- 2023-10: 1.9M
- 2023-11: 5.4M
- 2023-12: 3.1M
- 2024-02: 8.1M
- 2024-03: 3.1M
- 2024-05: 5.5M
- 2024-06: 3.3M
- 2024-07: 3M
- 2024-08: 1.3M
- 2024-09: 2.5M
- 2024-10: 2.2M
- 2024-11: 2M
- 2024-12: 1.8M
- 2025-01: 4.7M
- 2025-02: 1M
- 2025-03: 2.5M
- 2025-04: 2.9M
- 2025-05: 2.5M
- 2025-06: 1.9M
- 2025-07: 3M
- 2025-08: 1.3M
- 2025-09: 2.8M
- 2025-10: 661.9K
- 2025-11: 2M
- 2025-12: 3.1M
- 2026-01: 1.9M
- 2026-03: 697.5K
- 2026-04: 3.1M
- 2026-05: 1.7M
- 2026-06: 1.3M
- 2026-07: 799.3K
- 2026-08: 117.8K
- Main export countries
- India (0.6%)
- Sri Lanka (0%)
- Namibia (0%)
- Mexico (99.3%)
- Transactions
47
2019-012020-102021-09Transaction trend for Puyang Hotway Pharmacy Co., Ltd.
- 2019-01: 32
- 2019-11: 2
- 2020-04: 2
- 2020-05: 1
- 2020-06: 1
- 2020-10: 1
- 2021-03: 2
- 2021-04: 1
- 2021-05: 1
- 2021-07: 1
- 2021-08: 1
- 2021-09: 2
- Amount
559,462.81
2019-012020-102021-09Amount trend for Puyang Hotway Pharmacy Co., Ltd.
- 2019-01: 5.6B
- 2019-11: 24.9K
- 2020-04: 22.1K
- 2020-05: 11.8K
- 2020-06: 12.3K
- 2020-10: 11.9K
- 2021-03: 24.6K
- 2021-04: 12.5K
- 2021-05: 12.7K
- 2021-07: 12.5K
- 2021-08: 12.5K
- 2021-09: 25.3K
- Main export countries
- Indonesia (100%)
- Transactions
2,150
2018-012022-072026-09Transaction trend for Humanwell Puracap Pharmaceutical Co.
- 2018-01: 9
- 2018-02: 12
- 2018-03: 11
- 2018-04: 7
- 2018-05: 11
- 2018-06: 19
- 2018-07: 14
- 2018-08: 21
- 2018-09: 20
- 2018-10: 15
- 2018-11: 15
- 2018-12: 10
- 2019-01: 21
- 2019-02: 4
- 2019-03: 10
- 2019-04: 12
- 2019-05: 19
- 2019-06: 9
- 2019-07: 7
- 2019-08: 17
- 2019-09: 14
- 2019-10: 9
- 2019-11: 22
- 2019-12: 14
- 2020-01: 14
- 2020-02: 16
- 2020-03: 5
- 2020-05: 6
- 2020-06: 22
- 2020-08: 18
- 2020-10: 20
- 2020-11: 21
- 2020-12: 8
- 2021-02: 8
- 2021-03: 19
- 2021-04: 10
- 2021-05: 15
- 2021-06: 9
- 2021-07: 16
- 2021-08: 11
- 2021-09: 8
- 2021-10: 18
- 2021-11: 20
- 2021-12: 28
- 2022-01: 12
- 2022-02: 18
- 2022-03: 19
- 2022-05: 17
- 2022-06: 19
- 2022-07: 25
- 2022-08: 15
- 2022-09: 41
- 2022-10: 25
- 2022-11: 28
- 2022-12: 38
- 2023-01: 30
- 2023-02: 11
- 2023-03: 43
- 2023-04: 42
- 2023-05: 29
- 2023-06: 18
- 2023-07: 25
- 2023-08: 19
- 2023-09: 15
- 2023-10: 27
- 2023-11: 24
- 2023-12: 20
- 2024-01: 44
- 2024-02: 34
- 2024-03: 21
- 2024-04: 37
- 2024-05: 32
- 2024-06: 19
- 2024-07: 16
- 2024-08: 14
- 2024-09: 21
- 2024-10: 35
- 2024-11: 44
- 2024-12: 56
- 2025-01: 39
- 2025-02: 43
- 2025-03: 41
- 2025-04: 28
- 2025-05: 31
- 2025-06: 21
- 2025-07: 32
- 2025-08: 13
- 2025-09: 16
- 2025-10: 20
- 2025-11: 15
- 2025-12: 16
- 2026-01: 24
- 2026-02: 22
- 2026-03: 30
- 2026-04: 23
- 2026-05: 37
- 2026-06: 46
- 2026-07: 14
- 2026-08: 14
- 2026-09: 24
- Amount
82,855.66
2018-012022-072026-09Amount trend for Humanwell Puracap Pharmaceutical Co.
- 2018-01: 3.5M
- 2018-02: 4.8M
- 2018-03: 4.8M
- 2018-04: 1.9M
- 2018-05: 2M
- 2018-06: 5.1M
- 2018-07: 2.9M
- 2018-08: 5.5M
- 2018-09: 5.5M
- 2018-10: 4.2M
- 2018-11: 7.5M
- 2018-12: 2.4M
- 2019-01: 6.4M
- 2019-02: 1.4M
- 2019-03: 5.2M
- 2019-04: 4.2M
- 2019-05: 5.2M
- 2019-06: 3M
- 2019-07: 2.3M
- 2019-08: 5M
- 2019-09: 4.6M
- 2019-10: 3.7M
- 2019-11: 6.6M
- 2019-12: 2.5M
- 2020-01: 3.7M
- 2020-02: 5.3M
- 2020-03: 1.8M
- 2020-05: 1.9M
- 2020-06: 12.1M
- 2020-08: 5.9M
- 2020-10: 10.2M
- 2020-11: 13M
- 2020-12: 4.8M
- 2021-02: 2.9M
- 2021-03: 11.4M
- 2021-04: 4.8M
- 2021-05: 6M
- 2021-06: 5.5M
- 2021-07: 8.9M
- 2021-08: 7.6M
- 2021-09: 3.1M
- 2021-10: 9.9M
- 2021-11: 11.6M
- 2021-12: 13.5M
- 2022-01: 7.1M
- 2022-02: 12.3M
- 2022-03: 9.4M
- 2022-05: 8.1M
- 2022-06: 14.3M
- 2022-07: 16.1M
- 2022-08: 6.7M
- 2022-09: 15.5M
- 2022-10: 10.7M
- 2022-11: 12.3M
- 2022-12: 36.8M
- 2023-01: 13.5M
- 2023-02: 5.4M
- 2023-03: 17.7M
- 2023-04: 21M
- 2023-05: 11M
- 2023-06: 11.2M
- 2023-07: 9.1M
- 2023-08: 8.5M
- 2023-09: 6.3M
- 2023-10: 9.8M
- 2023-11: 9.2M
- 2023-12: 7.8M
- 2024-01: 16.7M
- 2024-02: 13.6M
- 2024-03: 6.9M
- 2024-04: 11M
- 2024-05: 10.4M
- 2024-06: 7.2M
- 2024-07: 9.3M
- 2024-08: 6.6M
- 2024-09: 5.2M
- 2024-10: 11.5M
- 2024-11: 10.1M
- 2024-12: 12.5M
- 2025-01: 10.9M
- 2025-02: 9.8M
- 2025-03: 7.5M
- 2025-04: 4.7M
- 2025-05: 7.4M
- 2025-06: 4.7M
- 2025-07: 12.4M
- 2025-08: 3.5M
- 2025-09: 5.5M
- 2025-10: 5.4M
- 2025-11: 3.7M
- 2025-12: 4.2M
- 2026-01: 6.1M
- 2026-02: 6.3M
- 2026-03: 8.5M
- 2026-04: 6.3M
- 2026-05: 16.2M
- 2026-06: 13.9M
- 2026-07: 3.7M
- 2026-08: 4.2M
- 2026-09: 6.8M
- Main export countries
- United States (99.1%)
- India (0%)
- Not available (0.9%)
Intelligence
China export momentum, destination markets, and regional demand.
China export trend
China export trend
- Date 2018-07: Value 2.8B USD
- Date 2018-08: Value 2.7B USD
- Date 2018-09: Value 2.4B USD
- Date 2018-10: Value 2.5B USD
- Date 2018-11: Value 3.1B USD
- Date 2018-12: Value 3B USD
- Date 2019-01: Value 3B USD
- Date 2019-02: Value 2B USD
- Date 2019-03: Value 3.1B USD
- Date 2019-04: Value 3.3B USD
- Date 2019-05: Value 3.7B USD
- Date 2019-06: Value 3B USD
- Date 2019-07: Value 3.3B USD
- Date 2019-08: Value 3.2B USD
- Date 2019-09: Value 3.2B USD
- Date 2019-10: Value 3.4B USD
- Date 2019-11: Value 3.8B USD
- Date 2019-12: Value 3.7B USD
- Date 2020-01: Value 0 USD
- Date 2020-02: Value 5.5B USD
- Date 2020-03: Value 4B USD
- Date 2020-04: Value 3.8B USD
- Date 2020-05: Value 3.1B USD
- Date 2020-06: Value 0 USD
- Date 2020-07: Value 0 USD
- Date 2020-08: Value 0 USD
- Date 2020-09: Value 3.8B USD
- Date 2020-10: Value 2.8B USD
- Date 2020-11: Value 3.4B USD
- Date 2020-12: Value 3B USD
- Date 2021-01: Value 204M USD
- Date 2021-02: Value 171M USD
- Date 2021-03: Value 205M USD
- Date 2021-04: Value 228M USD
- Date 2021-05: Value 195M USD
- Date 2021-06: Value 198M USD
- Date 2021-07: Value 221M USD
- Date 2021-08: Value 193M USD
- Date 2021-09: Value 228M USD
- Date 2021-10: Value 232M USD
- Date 2021-11: Value 224M USD
- Date 2021-12: Value 252M USD
- Date 2022-01: Value 252M USD
- Date 2022-02: Value 183M USD
- Date 2022-03: Value 269M USD
- Date 2022-04: Value 226M USD
- Date 2022-05: Value 242M USD
- Date 2022-06: Value 220M USD
- Date 2022-07: Value 245M USD
- Date 2022-08: Value 237M USD
- Date 2022-09: Value 230M USD
- Date 2022-10: Value 199M USD
- Date 2022-11: Value 252M USD
- Date 2022-12: Value 217M USD
- Date 2023-01: Value 198M USD
- Date 2023-02: Value 188M USD
- Date 2023-03: Value 227M USD
- Date 2023-04: Value 212M USD
- Date 2023-05: Value 247M USD
- Date 2023-06: Value 238M USD
- Date 2023-07: Value 191M USD
- Date 2023-08: Value 230M USD
- Date 2023-09: Value 238M USD
- Date 2023-10: Value 179M USD
- Date 2023-11: Value 217M USD
- Date 2023-12: Value 244M USD
- Date 2024-01: Value 335M USD
- Date 2024-02: Value 212M USD
- Date 2024-03: Value 301M USD
- Date 2024-04: Value 268M USD
- Date 2024-05: Value 228M USD
- Date 2024-06: Value 306M USD
- Date 2024-07: Value 269M USD
- Date 2024-08: Value 289M USD
- Date 2024-09: Value 282M USD
- Date 2024-10: Value 263M USD
- Date 2024-11: Value 296M USD
- Date 2024-12: Value 365M USD
- Date 2025-01: Value 330M USD
- Date 2025-02: Value 236M USD
- Date 2025-03: Value 309M USD
- Date 2025-04: Value 297M USD
- Date 2025-05: Value 301M USD
- Date 2025-06: Value 299M USD
- Date 2025-07: Value 320M USD
- Date 2025-08: Value 299M USD
- Date 2025-09: Value 305M USD
- Date 2025-10: Value 214M USD
- Date 2025-11: Value 326M USD
- Date 2025-12: Value 335M USD
- Date 2026-01: Value 353M USD
- Date 2026-02: Value 251M USD
- Date 2026-03: Value 296M USD
- Date 2026-04: Value 331M USD
- Date 2026-05: Value 293M USD
- Date 2026-06: Value 361M USD
- Date 2026-07: Value 345M USD
Top destinations
- Germany22.3B
- United States10.8B
- France7.1B
- Italy6.9B
- Sweden6.9B
- United Kingdom4.8B
- Japan3.8B
- Switzerland3.3B
- Australia3.1B
- Puerto Rico2.7B
Top destinations
- Germany: 22,334,000,000 USD
- United States: 10,831,000,000 USD
- France: 7,070,000,000 USD
- Italy: 6,949,000,000 USD
- Sweden: 6,944,000,000 USD
- United Kingdom: 4,812,000,000 USD
- Japan: 3,780,000,000 USD
- Switzerland: 3,275,000,000 USD
- Australia: 3,082,000,000 USD
- Puerto Rico: 2,732,000,000 USD
Key findings
Largest import market
22.33B USD
Germany · last 8 years
Fastest demand growth
56,399.16
Montenegro · last 8 years
Highest unit price
$1,411.12 /kg
Macao, China · +8,293.78% vs avg
Turn this market into qualified conversations.
Your agent contacts, compares, and screens the suppliers that fit.
Insights
Product insights to guide your sourcing.
Product Trends
Combination formulas like Ivermectin with Clorsulon see rising demand to combat drug resistance. Ready-to-use oral solutions and highly soluble powders are growing faster than tablets due to easier dosing in livestock and pets.
Industrial Cluster Analysis
Shijiazhuang in Hebei is the premier hub for finished veterinary formulations and GMP manufacturing. Shandong specializes in high-purity API synthesis, offering robust registration dossier support for global buyers.
Quality Expectations
Active ingredients must achieve over 99% purity, meeting USP or EP standards. Finished formulations require certified GMP documentation, strict microbiological limits, and verified stability for a 24-month shelf life.
What You Need to Know
Request a Certificate of Analysis (COA) for the specific batch, a GMP certificate, and a small sample for laboratory HPLC purity testing. For formulation products, ask for stability study data and impurity profile reports.
APIs typically require a minimum order of 25kg, while finished liquids require 1,000 pieces. Production takes 20 to 30 days depending on GMP scheduling and custom packaging, excluding sea freight transit times.
Budget for third-party laboratory testing, export customs clearance, specialized hazardous or temperature-controlled shipping packaging, and costs related to pharmaceutical registration filings in the destination country.
